These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 30463938)

  • 1. CRISPR/Cas9 and glycomics tools for
    Gas-Pascual E; Ichikawa HT; Sheikh MO; Serji MI; Deng B; Mandalasi M; Bandini G; Samuelson J; Wells L; West CM
    J Biol Chem; 2019 Jan; 294(4):1104-1125. PubMed ID: 30463938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sweet and CRISP(R)y parasite engineering.
    Wilson IBH; Schabussova I
    J Biol Chem; 2019 Jan; 294(4):1126-1127. PubMed ID: 30807998
    [No Abstract]   [Full Text] [Related]  

  • 3. Optimizing Systems for Cas9 Expression in Toxoplasma gondii.
    Markus BM; Bell GW; Lorenzi HA; Lourido S
    mSphere; 2019 Jun; 4(3):. PubMed ID: 31243081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR-Mediated Transcriptional Repression in Toxoplasma gondii.
    Markus BM; Boydston EA; Lourido S
    mSphere; 2021 Oct; 6(5):e0047421. PubMed ID: 34643425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional Characterization of Dense Granule Proteins in
    Bai MJ; Wang JL; Elsheikha HM; Liang QL; Chen K; Nie LB; Zhu XQ
    Front Cell Infect Microbiol; 2018; 8():300. PubMed ID: 30211128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A GlycoGene CRISPR-Cas9 lentiviral library to study lectin binding and human glycan biosynthesis pathways.
    Zhu Y; Groth T; Kelkar A; Zhou Y; Neelamegham S
    Glycobiology; 2021 Apr; 31(3):173-180. PubMed ID: 32776087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative O-glycomics based on improvement of the one-pot method for nonreductive O-glycan release and simultaneous stable isotope labeling with 1-(d
    Wang C; Zhang P; Jin W; Li L; Qiang S; Zhang Y; Huang L; Wang Z
    J Proteomics; 2017 Jan; 150():18-30. PubMed ID: 27585995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integration of Web-Based Tools to Visualize, Integrate, and Interpret Glycogene Expression and Glycomics Data.
    Subramanian SP; Gundry RL
    Methods Mol Biol; 2024; 2836():97-109. PubMed ID: 38995538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoenzymatic modular assembly of O-GalNAc glycans for functional glycomics.
    Wang S; Chen C; Gadi MR; Saikam V; Liu D; Zhu H; Bollag R; Liu K; Chen X; Wang F; Wang PG; Ling P; Guan W; Li L
    Nat Commun; 2021 Jun; 12(1):3573. PubMed ID: 34117223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomics and glycomics analyses of N-glycosylated structures involved in Toxoplasma gondii--host cell interactions.
    Fauquenoy S; Morelle W; Hovasse A; Bednarczyk A; Slomianny C; Schaeffer C; Van Dorsselaer A; Tomavo S
    Mol Cell Proteomics; 2008 May; 7(5):891-910. PubMed ID: 18187410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular O-Glycome Reporter/Amplification (CORA): Analytical and Preparative Tools to Study Mucin-Type O-Glycans of Living Cells.
    Kudelka MR; Li Z; Chernova TA; Smith DF; Song X; Cummings RD; Ju T
    Curr Protoc; 2021 Jun; 1(6):e142. PubMed ID: 34101390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suggestive evidence for Darwinian Selection against asparagine-linked glycans of Plasmodium falciparum and Toxoplasma gondii.
    Bushkin GG; Ratner DM; Cui J; Banerjee S; Duraisingh MT; Jennings CV; Dvorin JD; Gubbels MJ; Robertson SD; Steffen M; O'Keefe BR; Robbins PW; Samuelson J
    Eukaryot Cell; 2010 Feb; 9(2):228-41. PubMed ID: 19783771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Essential Functions of Glycans in Human Epithelia Dissected by a CRISPR-Cas9-Engineered Human Organotypic Skin Model.
    Dabelsteen S; Pallesen EMH; Marinova IN; Nielsen MI; Adamopoulou M; Rømer TB; Levann A; Andersen MM; Ye Z; Thein D; Bennett EP; Büll C; Moons SJ; Boltje T; Clausen H; Vakhrushev SY; Bagdonaite I; Wandall HH
    Dev Cell; 2020 Sep; 54(5):669-684.e7. PubMed ID: 32710848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amplification and Preparation of Cellular O-Glycomes for Functional Glycomics.
    Li Z; Zhang Q; Ashline D; Zhu Y; Lasanajak Y; Chernova T; Reinhold V; Cummings RD; Wang PG; Ju T; Smith DF; Song X
    Anal Chem; 2020 Aug; 92(15):10390-10401. PubMed ID: 32539345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mSphere of Influence: Ushering in the CRISPR Revolution to
    Guerra AJ
    mSphere; 2019 Jul; 4(4):. PubMed ID: 31270169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxoplasma CRISPR/Cas9 constructs are functional for gene disruption in Neospora caninum.
    Arranz-Solís D; Regidor-Cerrillo J; Lourido S; Ortega-Mora LM; Saeij JPJ
    Int J Parasitol; 2018 Jul; 48(8):597-600. PubMed ID: 29625127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of N-glycans and expression of their related glycogenes in the epithelial-mesenchymal transition of HCV29 bladder epithelial cells.
    Guo J; Li X; Tan Z; Lu W; Yang G; Guan F
    Molecules; 2014 Dec; 19(12):20073-90. PubMed ID: 25470275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycobiology of the ocular surface: mucins and lectins.
    Argüeso P
    Jpn J Ophthalmol; 2013 Mar; 57(2):150-5. PubMed ID: 23325272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient gene disruption in diverse strains of Toxoplasma gondii using CRISPR/CAS9.
    Shen B; Brown KM; Lee TD; Sibley LD
    mBio; 2014 May; 5(3):e01114-14. PubMed ID: 24825012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of functions in parasite growth and virulence of four Toxoplasma gondii genes involved in lipid synthesis by CRISPR-Cas9 system.
    Liu J; Li TT; Liang QL; Elsheikha HM; Zhao DY; Zhang ZW; Xu XP; Zhu XQ; Wang M
    Parasitol Res; 2021 Nov; 120(11):3749-3759. PubMed ID: 34499198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.